Alegitazar

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alegitazar, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study) [Phase 3]